60 DEGREES PHARMACEUTICALS, INC. - SXTP

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2026 · Compare: Q4 2025
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Kathmere Capital Management, LLC History New 144,683 253 0.02% 1 +144,683 New Q1 2026 Apr 28, 2026
JANE STREET GROUP, LLC History Closed out 0 0 0.0% -22,051 -100.0% Q4 2025 Feb 12, 2026
GEODE CAPITAL MANAGEMENT, LLC History Closed out 0 0 0.0% -12,449 -100.0% Q4 2025 Feb 09, 2026
Tower Research Capital LLC (TRC) History Closed out 0 0 0.0% -6,738 -100.0% Q4 2025 Feb 17, 2026
BARCLAYS PLC History Closed out 0 0 -1,513 -100.0% Q4 2025 Feb 13, 2026
UBS Group AG History Closed out 0 0 -1,476 -100.0% Q4 2025 Jan 29, 2026
OSAIC HOLDINGS, INC. History Closed out 0 0 -100 -100.0% Q4 2025 Feb 17, 2026
BANK OF AMERICA CORP /DE/ History Closed out 0 0 -31 -100.0% Q4 2025 Feb 17, 2026